Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aegera presents novel IAP inhibitors

Feb. 12, 2010

Data Monitoring Committee recommends continuation of phase III StemEx trial

Feb. 12, 2010

Gene recurrence score may be useful for prognosis in node-positive breast cancer

Feb. 12, 2010

4SC begins dosing in first-in-man phase I trial of 4SC-205 in cancer

Feb. 11, 2010

Novartis describes identification of compounds targeting PI3K

Feb. 11, 2010

Cancer Research Technology claims novel dual CYP26 inhibitors/RAMBAs

Feb. 11, 2010

The CXCR1antagonist repertaxin targets breast cancer stem cells in vivo

Feb. 11, 2010

Tamoxifen plus chemotherapy beneficial in postmenopausal breast cancer patients

Feb. 11, 2010

Progenics reports the identification of a wide range of PI3K inhibitors

Feb. 10, 2010

Denosumab superior to Zometa in prostate cancer patients with bone metastases

Feb. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...